IBDEI01M ; ; 01-AUG-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3514,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,3514,1,2,0)
 ;;=2^Flu Vacc High Dose Syr (FLUZONE)
 ;;^UTILITY(U,$J,358.3,3514,1,3,0)
 ;;=3^90662
 ;;^UTILITY(U,$J,358.3,3515,0)
 ;;=90664^^25^218^2^^^^1
 ;;^UTILITY(U,$J,358.3,3515,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,3515,1,2,0)
 ;;=2^Flu Vacc Intranasal,Pandemic,Live
 ;;^UTILITY(U,$J,358.3,3515,1,3,0)
 ;;=3^90664
 ;;^UTILITY(U,$J,358.3,3516,0)
 ;;=90672^^25^218^3^^^^1
 ;;^UTILITY(U,$J,358.3,3516,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,3516,1,2,0)
 ;;=2^Flu Vacc Intranasal,Quadrivalent,Live
 ;;^UTILITY(U,$J,358.3,3516,1,3,0)
 ;;=3^90672
 ;;^UTILITY(U,$J,358.3,3517,0)
 ;;=90674^^25^218^4^^^^1
 ;;^UTILITY(U,$J,358.3,3517,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,3517,1,2,0)
 ;;=2^Flu Vacc Low Dose Syr (FLUCELVAX CCIIV4)
 ;;^UTILITY(U,$J,358.3,3517,1,3,0)
 ;;=3^90674
 ;;^UTILITY(U,$J,358.3,3518,0)
 ;;=90688^^25^218^5^^^^1
 ;;^UTILITY(U,$J,358.3,3518,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,3518,1,2,0)
 ;;=2^Flu Vacc Multi Dose Syr (FLULAVAL)
 ;;^UTILITY(U,$J,358.3,3518,1,3,0)
 ;;=3^90688
 ;;^UTILITY(U,$J,358.3,3519,0)
 ;;=90658^^25^218^6^^^^1
 ;;^UTILITY(U,$J,358.3,3519,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,3519,1,2,0)
 ;;=2^Flu Vacc Multi Dose Vial (AFLURIA IIV3)
 ;;^UTILITY(U,$J,358.3,3519,1,3,0)
 ;;=3^90658
 ;;^UTILITY(U,$J,358.3,3520,0)
 ;;=90656^^25^218^9^^^^1
 ;;^UTILITY(U,$J,358.3,3520,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,3520,1,2,0)
 ;;=2^Flu Vacc Sgl Dose Syr iAFLURIA IIV3)
 ;;^UTILITY(U,$J,358.3,3520,1,3,0)
 ;;=3^90656
 ;;^UTILITY(U,$J,358.3,3521,0)
 ;;=90653^^25^218^8^^^^1
 ;;^UTILITY(U,$J,358.3,3521,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,3521,1,2,0)
 ;;=2^Flu Vacc Sgl Dose Syr (FLUAD)
 ;;^UTILITY(U,$J,358.3,3521,1,3,0)
 ;;=3^90653
 ;;^UTILITY(U,$J,358.3,3522,0)
 ;;=90682^^25^218^10^^^^1
 ;;^UTILITY(U,$J,358.3,3522,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,3522,1,2,0)
 ;;=2^Flublok (RIV4)
 ;;^UTILITY(U,$J,358.3,3522,1,3,0)
 ;;=3^90682
 ;;^UTILITY(U,$J,358.3,3523,0)
 ;;=90671^^25^218^11^^^^1
 ;;^UTILITY(U,$J,358.3,3523,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,3523,1,2,0)
 ;;=2^Pneumococcal Conjugate Vaccine,15 Valent (PCV15)
 ;;^UTILITY(U,$J,358.3,3523,1,3,0)
 ;;=3^90671
 ;;^UTILITY(U,$J,358.3,3524,0)
 ;;=90677^^25^218^12^^^^1
 ;;^UTILITY(U,$J,358.3,3524,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,3524,1,2,0)
 ;;=2^Pneumococcal Conjugate Vaccine,20 Valent (PCV20)
 ;;^UTILITY(U,$J,358.3,3524,1,3,0)
 ;;=3^90677
 ;;^UTILITY(U,$J,358.3,3525,0)
 ;;=95249^^25^219^2^^^^1
 ;;^UTILITY(U,$J,358.3,3525,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,3525,1,2,0)
 ;;=2^CGM SETUP/TRNG,MIN 72 HRS,PT PROVIDED EQUIP
 ;;^UTILITY(U,$J,358.3,3525,1,3,0)
 ;;=3^95249
 ;;^UTILITY(U,$J,358.3,3526,0)
 ;;=95250^^25^219^3^^^^1
 ;;^UTILITY(U,$J,358.3,3526,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,3526,1,2,0)
 ;;=2^CGM SETUP/TRNG,MIN 72 HRS,QHP PROVIDED EQUIP
 ;;^UTILITY(U,$J,358.3,3526,1,3,0)
 ;;=3^95250
 ;;^UTILITY(U,$J,358.3,3527,0)
 ;;=95251^^25^219^1^^^^1
 ;;^UTILITY(U,$J,358.3,3527,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,3527,1,2,0)
 ;;=2^CGM ANALYSIS,INTERP & RPT ONLY,MIN 72 HRS
 ;;^UTILITY(U,$J,358.3,3527,1,3,0)
 ;;=3^95251
 ;;^UTILITY(U,$J,358.3,3528,0)
 ;;=D68.318^^26^220^22
 ;;^UTILITY(U,$J,358.3,3528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3528,1,3,0)
 ;;=3^Hemorrhagic Disorder d/t Intrinsic Circ Anticoagulants
 ;;^UTILITY(U,$J,358.3,3528,1,4,0)
 ;;=4^D68.318
 ;;^UTILITY(U,$J,358.3,3528,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,3529,0)
 ;;=D68.9^^26^220^19
 ;;^UTILITY(U,$J,358.3,3529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3529,1,3,0)
 ;;=3^Coagulation Defect,Unspec
 ;;^UTILITY(U,$J,358.3,3529,1,4,0)
 ;;=4^D68.9
 ;;^UTILITY(U,$J,358.3,3529,2)
 ;;=^5002364
 ;;^UTILITY(U,$J,358.3,3530,0)
 ;;=D68.8^^26^220^20
 ;;^UTILITY(U,$J,358.3,3530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3530,1,3,0)
 ;;=3^Coagulation Defects,Other Spec
 ;;^UTILITY(U,$J,358.3,3530,1,4,0)
 ;;=4^D68.8
 ;;^UTILITY(U,$J,358.3,3530,2)
 ;;=^5002363
 ;;^UTILITY(U,$J,358.3,3531,0)
 ;;=D68.51^^26^220^1
 ;;^UTILITY(U,$J,358.3,3531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3531,1,3,0)
 ;;=3^Activated Protein C Resistance
 ;;^UTILITY(U,$J,358.3,3531,1,4,0)
 ;;=4^D68.51
 ;;^UTILITY(U,$J,358.3,3531,2)
 ;;=^5002358
 ;;^UTILITY(U,$J,358.3,3532,0)
 ;;=D68.59^^26^220^31
 ;;^UTILITY(U,$J,358.3,3532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3532,1,3,0)
 ;;=3^Primary Thrombophilia
 ;;^UTILITY(U,$J,358.3,3532,1,4,0)
 ;;=4^D68.59
 ;;^UTILITY(U,$J,358.3,3532,2)
 ;;=^5002360
 ;;^UTILITY(U,$J,358.3,3533,0)
 ;;=D68.61^^26^220^5
 ;;^UTILITY(U,$J,358.3,3533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3533,1,3,0)
 ;;=3^Antiphospholipid Syndrome
 ;;^UTILITY(U,$J,358.3,3533,1,4,0)
 ;;=4^D68.61
 ;;^UTILITY(U,$J,358.3,3533,2)
 ;;=^185421
 ;;^UTILITY(U,$J,358.3,3534,0)
 ;;=D68.62^^26^220^25
 ;;^UTILITY(U,$J,358.3,3534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3534,1,3,0)
 ;;=3^Lupus Anticoagulant Syndrome
 ;;^UTILITY(U,$J,358.3,3534,1,4,0)
 ;;=4^D68.62
 ;;^UTILITY(U,$J,358.3,3534,2)
 ;;=^5002361
 ;;^UTILITY(U,$J,358.3,3535,0)
 ;;=I26.99^^26^220^33
 ;;^UTILITY(U,$J,358.3,3535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3535,1,3,0)
 ;;=3^Pulmonary Embolism w/o Acute Cor Pulmonale,Other
 ;;^UTILITY(U,$J,358.3,3535,1,4,0)
 ;;=4^I26.99
 ;;^UTILITY(U,$J,358.3,3535,2)
 ;;=^5007150
 ;;^UTILITY(U,$J,358.3,3536,0)
 ;;=I42.5^^26^220^34
 ;;^UTILITY(U,$J,358.3,3536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3536,1,3,0)
 ;;=3^Restrictive Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,3536,1,4,0)
 ;;=4^I42.5
 ;;^UTILITY(U,$J,358.3,3536,2)
 ;;=^5007196
 ;;^UTILITY(U,$J,358.3,3537,0)
 ;;=I48.91^^26^220^11
 ;;^UTILITY(U,$J,358.3,3537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3537,1,3,0)
 ;;=3^Atrial Fibrillation,Unspec
 ;;^UTILITY(U,$J,358.3,3537,1,4,0)
 ;;=4^I48.91
 ;;^UTILITY(U,$J,358.3,3537,2)
 ;;=^5007229
 ;;^UTILITY(U,$J,358.3,3538,0)
 ;;=I48.92^^26^220^14
 ;;^UTILITY(U,$J,358.3,3538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3538,1,3,0)
 ;;=3^Atrial Flutter,Unspec
 ;;^UTILITY(U,$J,358.3,3538,1,4,0)
 ;;=4^I48.92
 ;;^UTILITY(U,$J,358.3,3538,2)
 ;;=^5007230
 ;;^UTILITY(U,$J,358.3,3539,0)
 ;;=I63.50^^26^220^15
 ;;^UTILITY(U,$J,358.3,3539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3539,1,3,0)
 ;;=3^Cerebral Infarction d/t Occls/Stenos of Cereb Artery
 ;;^UTILITY(U,$J,358.3,3539,1,4,0)
 ;;=4^I63.50
 ;;^UTILITY(U,$J,358.3,3539,2)
 ;;=^5007343
 ;;^UTILITY(U,$J,358.3,3540,0)
 ;;=G45.9^^26^220^40
 ;;^UTILITY(U,$J,358.3,3540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3540,1,3,0)
 ;;=3^Transient Cerebral Ischemic Attack,Unspec
 ;;^UTILITY(U,$J,358.3,3540,1,4,0)
 ;;=4^G45.9
 ;;^UTILITY(U,$J,358.3,3540,2)
 ;;=^5003959
 ;;^UTILITY(U,$J,358.3,3541,0)
 ;;=I73.9^^26^220^26
 ;;^UTILITY(U,$J,358.3,3541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3541,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,3541,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,3541,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,3542,0)
 ;;=I82.401^^26^220^3
 ;;^UTILITY(U,$J,358.3,3542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3542,1,3,0)
 ;;=3^Acute Embolism/Thrombos Deep Veins Right Lower Extremity
 ;;^UTILITY(U,$J,358.3,3542,1,4,0)
 ;;=4^I82.401
 ;;^UTILITY(U,$J,358.3,3542,2)
 ;;=^5007854
 ;;^UTILITY(U,$J,358.3,3543,0)
 ;;=I82.402^^26^220^2
 ;;^UTILITY(U,$J,358.3,3543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3543,1,3,0)
 ;;=3^Acute Embolism/Thrombos Deep Veins Left Lower Extremity
 ;;^UTILITY(U,$J,358.3,3543,1,4,0)
 ;;=4^I82.402
 ;;^UTILITY(U,$J,358.3,3543,2)
 ;;=^5007855
 ;;^UTILITY(U,$J,358.3,3544,0)
 ;;=I82.890^^26^220^4
 ;;^UTILITY(U,$J,358.3,3544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3544,1,3,0)
 ;;=3^Acute Embolism/Thrombosis of Specified Veins
 ;;^UTILITY(U,$J,358.3,3544,1,4,0)
 ;;=4^I82.890
 ;;^UTILITY(U,$J,358.3,3544,2)
 ;;=^5007938
 ;;^UTILITY(U,$J,358.3,3545,0)
 ;;=I82.91^^26^220^17
 ;;^UTILITY(U,$J,358.3,3545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3545,1,3,0)
 ;;=3^Chronic Embolism/Thrombosis Unspec Vein
 ;;^UTILITY(U,$J,358.3,3545,1,4,0)
 ;;=4^I82.91
 ;;^UTILITY(U,$J,358.3,3545,2)
 ;;=^5007941
 ;;^UTILITY(U,$J,358.3,3546,0)
 ;;=Z86.718^^26^220^29
 ;;^UTILITY(U,$J,358.3,3546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3546,1,3,0)
 ;;=3^Personal Hx of Venous Thrombosis/Embolism
 ;;^UTILITY(U,$J,358.3,3546,1,4,0)
 ;;=4^Z86.718
 ;;^UTILITY(U,$J,358.3,3546,2)
 ;;=^5063475
 ;;^UTILITY(U,$J,358.3,3547,0)
 ;;=Z86.711^^26^220^28
 ;;^UTILITY(U,$J,358.3,3547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3547,1,3,0)
 ;;=3^Personal Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,3547,1,4,0)
 ;;=4^Z86.711
 ;;^UTILITY(U,$J,358.3,3547,2)
 ;;=^5063474
 ;;^UTILITY(U,$J,358.3,3548,0)
 ;;=Z86.79^^26^220^27
 ;;^UTILITY(U,$J,358.3,3548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3548,1,3,0)
 ;;=3^Personal Hx of Circulatory System Diseases
 ;;^UTILITY(U,$J,358.3,3548,1,4,0)
 ;;=4^Z86.79
 ;;^UTILITY(U,$J,358.3,3548,2)
 ;;=^5063479
 ;;^UTILITY(U,$J,358.3,3549,0)
 ;;=Z95.2^^26^220^30
 ;;^UTILITY(U,$J,358.3,3549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3549,1,3,0)
 ;;=3^Presence of Prosthetic Heart Valve
 ;;^UTILITY(U,$J,358.3,3549,1,4,0)
 ;;=4^Z95.2
 ;;^UTILITY(U,$J,358.3,3549,2)
 ;;=^5063670
 ;;^UTILITY(U,$J,358.3,3550,0)
 ;;=Z79.01^^26^220^23
 ;;^UTILITY(U,$J,358.3,3550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3550,1,3,0)
 ;;=3^Long Term (Current) Use of Anticoagulants
 ;;^UTILITY(U,$J,358.3,3550,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,3550,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,3551,0)
 ;;=Z79.02^^26^220^24
 ;;^UTILITY(U,$J,358.3,3551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3551,1,3,0)
 ;;=3^Long Term (Current) Use of Antithrombotics/Antiplatelets
 ;;^UTILITY(U,$J,358.3,3551,1,4,0)
 ;;=4^Z79.02
 ;;^UTILITY(U,$J,358.3,3551,2)
 ;;=^5063331
 ;;^UTILITY(U,$J,358.3,3552,0)
 ;;=I25.9^^26^220^18
 ;;^UTILITY(U,$J,358.3,3552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3552,1,3,0)
 ;;=3^Chronic Ischemic Heart Disease,Unspec
 ;;^UTILITY(U,$J,358.3,3552,1,4,0)
 ;;=4^I25.9
 ;;^UTILITY(U,$J,358.3,3552,2)
 ;;=^5007144
 ;;^UTILITY(U,$J,358.3,3553,0)
 ;;=Z51.81^^26^220^39
 ;;^UTILITY(U,$J,358.3,3553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3553,1,3,0)
 ;;=3^Therapeutic Drug Level Monitoring
 ;;^UTILITY(U,$J,358.3,3553,1,4,0)
 ;;=4^Z51.81
 ;;^UTILITY(U,$J,358.3,3553,2)
 ;;=^5063064
 ;;^UTILITY(U,$J,358.3,3554,0)
 ;;=I63.9^^26^220^16
 ;;^UTILITY(U,$J,358.3,3554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3554,1,3,0)
 ;;=3^Cerebral Infarction,Unspec
 ;;^UTILITY(U,$J,358.3,3554,1,4,0)
 ;;=4^I63.9
 ;;^UTILITY(U,$J,358.3,3554,2)
 ;;=^5007355
 ;;^UTILITY(U,$J,358.3,3555,0)
 ;;=I82.3^^26^220^21
 ;;^UTILITY(U,$J,358.3,3555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3555,1,3,0)
 ;;=3^Embolism & Thrombosis,Renal Vein
 ;;^UTILITY(U,$J,358.3,3555,1,4,0)
 ;;=4^I82.3
 ;;^UTILITY(U,$J,358.3,3555,2)
 ;;=^269818
 ;;^UTILITY(U,$J,358.3,3556,0)
 ;;=I48.0^^26^220^9
 ;;^UTILITY(U,$J,358.3,3556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3556,1,3,0)
 ;;=3^Atrial Fibrillation,Paroxysmal
 ;;^UTILITY(U,$J,358.3,3556,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,3556,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,3557,0)
 ;;=I48.11^^26^220^7
 ;;^UTILITY(U,$J,358.3,3557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3557,1,3,0)
 ;;=3^Atrial Fibrillation,Longstanding Persistent
 ;;^UTILITY(U,$J,358.3,3557,1,4,0)
 ;;=4^I48.11
 ;;^UTILITY(U,$J,358.3,3557,2)
 ;;=^5158046
 ;;^UTILITY(U,$J,358.3,3558,0)
 ;;=I48.19^^26^220^8
 ;;^UTILITY(U,$J,358.3,3558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3558,1,3,0)
 ;;=3^Atrial Fibrillation,Other Persistent
 ;;^UTILITY(U,$J,358.3,3558,1,4,0)
 ;;=4^I48.19
 ;;^UTILITY(U,$J,358.3,3558,2)
 ;;=^5158047
 ;;^UTILITY(U,$J,358.3,3559,0)
 ;;=I48.20^^26^220^6
 ;;^UTILITY(U,$J,358.3,3559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3559,1,3,0)
 ;;=3^Atrial Fibrillation,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,3559,1,4,0)
 ;;=4^I48.20
 ;;^UTILITY(U,$J,358.3,3559,2)
 ;;=^5158048
 ;;^UTILITY(U,$J,358.3,3560,0)
 ;;=I48.21^^26^220^10
 ;;^UTILITY(U,$J,358.3,3560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3560,1,3,0)
 ;;=3^Atrial Fibrillation,Permanent
 ;;^UTILITY(U,$J,358.3,3560,1,4,0)
 ;;=4^I48.21
 ;;^UTILITY(U,$J,358.3,3560,2)
 ;;=^304710
 ;;^UTILITY(U,$J,358.3,3561,0)
 ;;=I48.3^^26^220^13
 ;;^UTILITY(U,$J,358.3,3561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3561,1,3,0)
 ;;=3^Atrial Flutter,Typical
 ;;^UTILITY(U,$J,358.3,3561,1,4,0)
 ;;=4^I48.3
 ;;^UTILITY(U,$J,358.3,3561,2)
 ;;=^5007227
 ;;^UTILITY(U,$J,358.3,3562,0)
 ;;=I48.4^^26^220^12
 ;;^UTILITY(U,$J,358.3,3562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3562,1,3,0)
 ;;=3^Atrial Flutter,Atypical
 ;;^UTILITY(U,$J,358.3,3562,1,4,0)
 ;;=4^I48.4
 ;;^UTILITY(U,$J,358.3,3562,2)
 ;;=^5007228
 ;;^UTILITY(U,$J,358.3,3563,0)
 ;;=I26.02^^26^220^35
 ;;^UTILITY(U,$J,358.3,3563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3563,1,3,0)
 ;;=3^Saddle Embolus,Pulm Artery w/ Acute Cor Pulmonale
 ;;^UTILITY(U,$J,358.3,3563,1,4,0)
 ;;=4^I26.02
 ;;^UTILITY(U,$J,358.3,3563,2)
 ;;=^5007146
 ;;^UTILITY(U,$J,358.3,3564,0)
 ;;=I26.09^^26^220^32
 ;;^UTILITY(U,$J,358.3,3564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3564,1,3,0)
 ;;=3^Pulmonary Embolism w/ Acute Cor Pulmonale,Other
 ;;^UTILITY(U,$J,358.3,3564,1,4,0)
 ;;=4^I26.09
 ;;^UTILITY(U,$J,358.3,3564,2)
 ;;=^5007147
 ;;^UTILITY(U,$J,358.3,3565,0)
 ;;=I26.92^^26^220^36
 ;;^UTILITY(U,$J,358.3,3565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3565,1,3,0)
 ;;=3^Saddle Embolus,Pulm Artery w/o Acute Cor Pulmonale
 ;;^UTILITY(U,$J,358.3,3565,1,4,0)
 ;;=4^I26.92
 ;;^UTILITY(U,$J,358.3,3565,2)
 ;;=^5007149
 ;;^UTILITY(U,$J,358.3,3566,0)
 ;;=I26.93^^26^220^38
 ;;^UTILITY(U,$J,358.3,3566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3566,1,3,0)
 ;;=3^Subseg Pulm Emb,Single w/o Acute Cor Pulmonale
 ;;^UTILITY(U,$J,358.3,3566,1,4,0)
 ;;=4^I26.93
 ;;^UTILITY(U,$J,358.3,3566,2)
 ;;=^5158044
 ;;^UTILITY(U,$J,358.3,3567,0)
 ;;=I26.94^^26^220^37
 ;;^UTILITY(U,$J,358.3,3567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3567,1,3,0)
 ;;=3^Subseg Pulm Emb,Mult w/o Acute Cor Pulmonale
 ;;^UTILITY(U,$J,358.3,3567,1,4,0)
 ;;=4^I26.94
 ;;^UTILITY(U,$J,358.3,3567,2)
 ;;=^5158045
 ;;^UTILITY(U,$J,358.3,3568,0)
 ;;=F11.20^^26^221^5
 ;;^UTILITY(U,$J,358.3,3568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3568,1,3,0)
 ;;=3^Opioid Dependence,Uncomplicated
 ;;^UTILITY(U,$J,358.3,3568,1,4,0)
 ;;=4^F11.20
 ;;^UTILITY(U,$J,358.3,3568,2)
 ;;=^5003127
 ;;^UTILITY(U,$J,358.3,3569,0)
 ;;=M19.90^^26^221^6
 ;;^UTILITY(U,$J,358.3,3569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3569,1,3,0)
 ;;=3^Osteoarthritis,Unspec Site
 ;;^UTILITY(U,$J,358.3,3569,1,4,0)
 ;;=4^M19.90
 ;;^UTILITY(U,$J,358.3,3569,2)
 ;;=^5010853
 ;;^UTILITY(U,$J,358.3,3570,0)
 ;;=Z79.891^^26^221^1
 ;;^UTILITY(U,$J,358.3,3570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3570,1,3,0)
 ;;=3^Long Term Opiate/Opioid Analgesic Use
 ;;^UTILITY(U,$J,358.3,3570,1,4,0)
 ;;=4^Z79.891
 ;;^UTILITY(U,$J,358.3,3570,2)
 ;;=^5063342
 ;;^UTILITY(U,$J,358.3,3571,0)
 ;;=M54.50^^26^221^3
 ;;^UTILITY(U,$J,358.3,3571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3571,1,3,0)
 ;;=3^Low Back Pain,Unspec
 ;;^UTILITY(U,$J,358.3,3571,1,4,0)
 ;;=4^M54.50
 ;;^UTILITY(U,$J,358.3,3571,2)
 ;;=^5161215
 ;;^UTILITY(U,$J,358.3,3572,0)
 ;;=M54.51^^26^221^4
 ;;^UTILITY(U,$J,358.3,3572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3572,1,3,0)
 ;;=3^Low Back Pain,Vertebrogenic
 ;;^UTILITY(U,$J,358.3,3572,1,4,0)
 ;;=4^M54.51
 ;;^UTILITY(U,$J,358.3,3572,2)
 ;;=^5161216
 ;;^UTILITY(U,$J,358.3,3573,0)
 ;;=M54.59^^26^221^2
 ;;^UTILITY(U,$J,358.3,3573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3573,1,3,0)
 ;;=3^Low Back Pain,Other
 ;;^UTILITY(U,$J,358.3,3573,1,4,0)
 ;;=4^M54.59
 ;;^UTILITY(U,$J,358.3,3573,2)
 ;;=^5161217
 ;;^UTILITY(U,$J,358.3,3574,0)
 ;;=F43.10^^26^222^6
 ;;^UTILITY(U,$J,358.3,3574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3574,1,3,0)
 ;;=3^PTSD,Unspec
 ;;^UTILITY(U,$J,358.3,3574,1,4,0)
 ;;=4^F43.10
 ;;^UTILITY(U,$J,358.3,3574,2)
 ;;=^5003570
 ;;^UTILITY(U,$J,358.3,3575,0)
 ;;=F43.12^^26^222^5
 ;;^UTILITY(U,$J,358.3,3575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3575,1,3,0)
 ;;=3^PTSD,Chronic
 ;;^UTILITY(U,$J,358.3,3575,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,3575,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,3576,0)
 ;;=F32.9^^26^222^3
 ;;^UTILITY(U,$J,358.3,3576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3576,1,3,0)
 ;;=3^MDD,Single Episode,Unspec
 ;;^UTILITY(U,$J,358.3,3576,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,3576,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,3577,0)
 ;;=F41.9^^26^222^2
 ;;^UTILITY(U,$J,358.3,3577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3577,1,3,0)
 ;;=3^Anxiety Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,3577,1,4,0)
 ;;=4^F41.9
 ;;^UTILITY(U,$J,358.3,3577,2)
 ;;=^5003567
 ;;^UTILITY(U,$J,358.3,3578,0)
 ;;=F10.20^^26^222^1
 ;;^UTILITY(U,$J,358.3,3578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3578,1,3,0)
 ;;=3^Alcohol Dependence,Uncomp (Mod or Severe)
 ;;^UTILITY(U,$J,358.3,3578,1,4,0)
 ;;=4^F10.20
 ;;^UTILITY(U,$J,358.3,3578,2)
 ;;=^5003081
 ;;^UTILITY(U,$J,358.3,3579,0)
 ;;=F06.8^^26^222^4
 ;;^UTILITY(U,$J,358.3,3579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3579,1,3,0)
 ;;=3^Mental Disorders d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,3579,1,4,0)
 ;;=4^F06.8
 ;;^UTILITY(U,$J,358.3,3579,2)
 ;;=^5003062
 ;;^UTILITY(U,$J,358.3,3580,0)
 ;;=F06.0^^26^222^7
 ;;^UTILITY(U,$J,358.3,3580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3580,1,3,0)
 ;;=3^Psychotic Disorder w/ Hallucinations d/t Physiol Condition
 ;;^UTILITY(U,$J,358.3,3580,1,4,0)
 ;;=4^F06.0
 ;;^UTILITY(U,$J,358.3,3580,2)
 ;;=^5003053
 ;;^UTILITY(U,$J,358.3,3581,0)
 ;;=F01.50^^26^222^9
 ;;^UTILITY(U,$J,358.3,3581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3581,1,3,0)
 ;;=3^Vascular Dementia w/o Behav Disturbance
 ;;^UTILITY(U,$J,358.3,3581,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,3581,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,3582,0)
 ;;=F01.51^^26^222^8
 ;;^UTILITY(U,$J,358.3,3582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3582,1,3,0)
 ;;=3^Vascular Dementia w/ Behav Disturbance
 ;;^UTILITY(U,$J,358.3,3582,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,3582,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,3583,0)
 ;;=E05.90^^26^223^25
 ;;^UTILITY(U,$J,358.3,3583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3583,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec
 ;;^UTILITY(U,$J,358.3,3583,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,3583,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,3584,0)
 ;;=E03.9^^26^223^18
 ;;^UTILITY(U,$J,358.3,3584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3584,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,3584,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,3584,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,3585,0)
 ;;=E11.9^^26^223^15
 ;;^UTILITY(U,$J,358.3,3585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3585,1,3,0)
 ;;=3^DM2 w/o Complications
